Secondary Prevention of Coronary Heart Disease Flashcards

1
Q

Secondary prevention definition

A

prevention actions taken after the development of disease to halt its progress and subsequent complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major goals of secondary prevention of CVD

A

o Goal #1: Prevention of plaque rupture and progression o Goal #2: Prevention of new plaque formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Major categories of tools used in secondary prevention of CVD

A

-medications: rely on health care system (and compliance) -lifestyle changes: rely’s mainly on patient and built environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Main pharmacologic secondary CVD prevention guidelines

A

-anti-platelets -beta-blockers -RAAS inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Main pharmacologic+lifestyle secondary CVD prevention guidelines

A

-Blood pressure control -Lipid management -Diabetes management -Depression screening and treatment -Smoking cessation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Main lifestyle secondary CVD prevention guidelines

A

-weight management -physical activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Other possible secondary CVD prevention guidelines

A

-cardiac rehabilitation -influenza vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti-platelets used in secondary CVD and rationale

A

-Anti-platelets prevent platelet adhesion to the site of a ruptured plaque, reduce platelet activation, and prevent platelet aggregation -Aspirin -Thienopyridines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thienopyridines MOA & examples

A

(clopidogrel, ticlodipine, prasugrel, and ticagrelor) Inhibits adenosine diphosphate (ADP) production and platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aspirin MOA

A

Reduces platelet activation by blocking cyclooxygenase and thromboxane A2 (a vasoconstrictor) production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Class I Antiplatelet guidelines

A
  • ALL CAD patients: asprin daily
  • PTS w/ACS or PCI for one year following the event: Thienopyridines + aspirin
  • PTS post-bypass surgery: aspirin (at least one year)
  • PTS post-stroke: aspirin alone, clopidogrel alone, or combined aspirin/dipyridamole daily chronically
  • PTS w/symptomatic peripheral arterial disease: aspirin alone or clopidogrel alone
  • PTS w/warfarin: continue low-dose aspirin and monitor closely for bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Class I beta-blocker guidelines

A

Beta-blockers in all with LVSD (ejection fraction <40%) and heart failure symptoms or MI/ACS in the prior 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Class IIa beta-blocker guidelines

A
  • Beta-blockers in all with LVSD (ejection fraction <40%) even in the absence of heart failure symptoms
  • Beta-blockers in all with any history of MI/ACS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Class I RAAS inhibition guidelines

A
  • ACEIs
    • All with LVSD (ejection fraction <40%), DM, HTN, or chronic kidney disease
  • ARBs
    • All with LVSD (ejection fraction <40%) and either a prior MI or heart failure symptoms and who are ACEI-intolerant
  • Aldosterone inhibition
    • Post-MI patients with LVSD (ejection fraction <40%) on BB and ACEI/ARB w/heart failure or diabetes.
    • Avoid in those with renal dysfunction or significant hyperkalemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class I BP control guidelines

A
  • Age <60yo: BP <140/90
  • Age ≥60yo: BP <150/90
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class I lipid guidelines

A
  • Statins in ALL CAD patients
  • No need to titrate to LDL
  • No indication for non-statin lipid-lowering therapies
  • Not proven in HF NYHA Class III-IV or hemodialysis patients
17
Q

Class I diabetes guidelines

A

-lifestyle modifications -coordination w/PCP

18
Q

Class IIa/IIb diabetes guidelines

A
  • IIa: metformin=first-line pharm therapy
  • IIb: HbA1c <7% can be considered as goal
19
Q

Class IIa/IIb depression guidelines

A
  • IIa: assess depression
  • IIb: tx may not improve cardiac outcomes but is at least beneficial to overall mental health
20
Q

Class I smoking guidelines

A

Stop that shit.

21
Q

Class I weight control guidelines

A
  • Goal BMI is 18.5-24.9
  • Goal waist circumference is <35 inches for women
  • Initial goals of weight loss should be 5-10% of body weight
22
Q

Class I physical activity guidelines

A

Just do it (mod-high intensity for 30-60 minutes/5-7 days/week)

23
Q
A